FDA Warns Hospira Over Issues At Costa Rican Plant
Hospira Inc. disclosed on Tuesday that it has received a warning letter from the U.S. Food and Drug Administration regarding quality issues uncovered during an inspection of a Costa Rican facility...To view the full article, register now.
Already a subscriber? Click here to view full article